How to diagnose delayed cerebral ischaemia and symptomatic v... : Current Opinion in Critical
Care How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent …

Interleukin 6 (IL-6) is a prominent proinflammatory cytokine. Neuroinflammation in general,
and IL-6 signaling in particular, appear to play a major role in the pathobiology and …

Abstract Interleukin 6 (IL-6) is a prominent proinflammatory cytokine and has been
discussed as a potential biomarker for delayed cerebral ischemia (DCI) following …

Background: During the last decade, cerebral vasospasm after aneurysmal subarachnoid
hemorrhage (SAH) was a current research focus without a standardized classification in …

Abstract Background Delayed cerebral infarction (DCIn) following aneurysmal subarachnoid
hemorrhage (aSAH) is a major cause of morbi-mortality; yet, the causes for DCIn remain …

OBJECTIVE In this study, the authors sought to define the differences in the incidence of
delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated …

Background and purpose Cone-beam CT angiography (CB-CTA) provides a three-
dimensional spatial resolution which is, so far, unmatched in clinical practice compared with …

Aneurysmal subarachnoid hemorrhage (ASAH) is a devastating condition with high
morbidity and mortality, with a reported incidence ranging from 2.0 to 22.5 per 100,000 …

Background Intra-arterial nimodipine (IAN) injections are performed in refractory delayed
cerebral ischemia (DCI) related to cerebral vasospasm (CVS) after spontaneous …

Background Vasospasm and delayed ischemic neurologic deficits are the leading causes of
morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). Several …